The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and during sepsis which is essentially like end game infection what they find is people will have high insulin or insulin resistance as well as high glucagon and this is actually something we're seeing in diabetics as well from the few points we have so far
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and that said I did start slipping in the glucagon test with some of my friends and family and one of my challenge cases as it turns out had very high glucagon along with very high insulin which isn't too uncommon for somebody in his particular situation